Heart Failure with Reduced Ejection Fraction-Does Sex Matter?
- PMID: 34778933
- PMCID: PMC8616864
- DOI: 10.1007/s11897-021-00533-y
Heart Failure with Reduced Ejection Fraction-Does Sex Matter?
Abstract
Purpose of review: There is an increasing recognition of the importance of sex in susceptibility, clinical presentation, and outcomes for heart failure. This review focusses on heart failure with reduced ejection fraction (HFrEF), unravelling differences in biology, clinical and demographic features and evidence for diagnostic and therapeutic strategies. This is intended to inform clinicians and researchers regarding state-of-the-art evidence relevant to women, as well as areas of unmet need.
Recent findings: Females are well recognised to be under-represented in clinical trials, but there have been some improvements in recent years. Data from the last 5 years reaffirms that women presenting with HFrEF women are older and have more comorbidities like hypertension, diabetes and obesity compared with men and are less likely to have ischaemic heart disease. Non-ischaemic aetiologies are more likely to be the cause of HFrEF in women, and women are more often symptomatic. Whilst mortality is less than in their male counterparts, HFrEF is associated with a bigger impact on quality of life in females. The implications of this for improved prevention, treatment and outcomes are discussed. This review reveals distinct sex differences in HFrEF pathophysiology, types of presentation, morbidity and mortality. In light of this, in order for future research and clinical medicine to be able to manage HFrEF adequately, there must be more representation of women in clinical trials as well as collaboration for the development of sex-specific management guidelines. Future research might also elucidate the biochemical foundation of the sex discrepancy in HFrEF.
Keywords: Female; Gender; Heart failure; Male; Reduced ejection fraction; Sex.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Lippi G, Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Med J 2020;5.
-
- Hsich EM, Grau-Sepulveda M, Hernandez AF, Eapen ZJ, Xian Y, Schwamm LH, et al. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry. Am Heart J. 2013;166(6):1063–1071. doi: 10.1016/j.ahj.2013.08.029. - DOI - PubMed
-
- Badran HM, Elgharably M, Faheem N. Clinical characteristics and in-hospital outcomes of heart failure in women: a single center registry from Egyptian cardiac care unit. . Egypt Heart J. 2019;71(1):doi.org/10.1186/s43044-019-0032-0. - PMC - PubMed
-
- Kocabas U, Kivrak T, Oztekin GMY, Tanik VO, Ozdemir I, Kaya E, et al. Gender related clinical and management differences in patients with chronic heart failure with reduced ejection fraction. . Int J Clin Pract. 2020;75(3):doi.org/10.1111/ijcp.13765. . - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
